Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxin Shutong Capsule for Chronic Stable Angina
NCT02280850Phase 4Unknown
- Sponsor
- Buchang Pharmaceuticals
- Start
- Oct 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in stable angina comparing Guanxin Shutong Capsule with Placebo Capsule (2 arms). Primary endpoints: Therapeutic effect to Angina (Average value of angina frequency) at 6 weeks and Exercise treadmill testing at 4 weeks. Status: unknown.
02
Drugs
Guanxin Shutong Capsule
03
Conditions
stable angina
Beyond the preview
Go deeper on NCT02280850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280850.